Health - KSYL-AM
Negelle Morris, senior vice president of Novo Nordisk, speaks out on "Good Morning America" about drugs used for weight loss. Via GMA(NEW YORK) -- An executive for Novo Nordisk, the maker of popular drugs used for weight loss including Ozempic and Wegovy, says the company is investing over $6 billion dollars to help meet the increased demand for the drugs amid ongoing shortages and high prices.Negelle Morris, senior vice president and head of U.S. cardiometabolic sales at Novo Nordisk Inc., warned though that even with the increased investment, there will still likely be a delay in g...